Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study aims to assess the applicability of the serum iodine (SI) standards proposed by the WHO and other renowned laboratories for the Chinese population. Additionally, it seeks to establish reference intervals (RIs) for SI in Chinese adults and conduct a risk assessment between serum iodine concentration (SIC) and the development of thyroid diseases. This study enrolled 3138 adults aged 18-60 years from six provinces in China. A total of 1794 healthy adults with normal thyroid function were selected to assess the applicability of the international standards and establish China's RI, utilizing five external datasets for validation. Multiple logistic regression analysis was applied to explore the relationship between SIC and thyroid disease. The ratios of adults with normal thyroid function from five provinces whose SI levels fall outside the limits of the international standards are partially greater than 10%. China's RI was 40.11-97.59 µg/L, and the ratios of individuals in the validation datasets outside this RI were all less than 10%. Adults with low SIC levels (< 40.11 µg/L) were at higher risk of hypothyroxinemia (adjusted OR = 4.715, 95% CI = 1.459-15.235), overt hypothyroidism (adjusted OR = 4.719, 95% CI = 1.583-14.067), and autoimmune thyroiditis (adjusted OR = 2.394, 95% CI = 1.410-4.064). Adults with high SIC levels (> 97.59 µg/L) were at a higher risk of overt hyperthyroidism (adjusted OR = 18.170, 95% CI = 5.940-55.577). These international standards are not fully applicable to the Chinese population. We established RIs for SI in Chinese adults to better accommodate the country's specific conditions.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12011-025-04549-6DOI Listing

Publication Analysis

Top Keywords

serum iodine
12
international standards
12
applicability serum
8
iodine standards
8
provinces china
8
assess applicability
8
chinese population
8
ris chinese
8
chinese adults
8
adults normal
8

Similar Publications

High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma.

Front Oncol

August 2025

Department of Pathology, Institute of Clinical Pathology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Despite the generally favorable prognosis of differentiated thyroid carcinoma (DTC) following surgery and radioactive iodine (RAI) therapy, approximately 10% of cases eventually develop resistance to RAI. This condition, known as radioiodine-refractory differentiated thyroid carcinoma (RAIR-DTC), is associated with a poor prognosis, with a 10-year survival rate of only 10% from the time of metastasis detection. The limited availability of safe and effective alternative treatments poses a significant challenge to clinical management.

View Article and Find Full Text PDF

Ferroptosis-Enhanced Radiopharmaceutical Therapy via a Manganese-Based Nanoplatform.

Mol Pharm

September 2025

Department of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.

Radiopharmaceutical therapy (RPT) is a therapeutic strategy that delivers radionuclides in a targeted manner to achieve precise radiation-induced killing of tumor cells. While RPT primarily induces tumor cell death through apoptosis, resistance to apoptosis has been identified as a key mechanism underlying the radioresistance. Therefore, integrating nonapoptotic cell death pathways with RPT offers a promising strategy to enhance its therapeutic efficacy.

View Article and Find Full Text PDF

Post Contrast-Acute Kidney Injury in CT Imaging: A Knowledge, Perception and Practice Assessment among Radiographers and Radiologists.

G Ital Nefrol

August 2025

Professor, Department of Radio Diagnosis, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur, 603203, Chengalpattu District, Tamil Nadu, India.

Contrast-induced nephropathy (CIN), often referred to as post-contrast acute kidney injury (PC-AKI), remains a significant issue in diagnostic imaging procedures that utilize iodinated contrast agents. This study aims to examine the knowledge, perceptions, and practices of radiologists and radiographers regarding PC-AKI. A survey was conducted among South Indian radiologists and radiographers in November and December of 2024.

View Article and Find Full Text PDF

Background And Objective: Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC) remains challenging to treat due to a lack of effective therapies. This study aimed to evaluate the efficacy and safety of combining anlotinib with iodine-125 (I) seed implantation in patients with RAIR-DTC.

Methods And Materials: We retrospectively compared three treatment groups in 52 patients with advanced RAIR-DTC: anlotinib monotherapy (Group A, = 14), I seed brachytherapy monotherapy (Group B, = 25), and combined therapy (Group C, = 13).

View Article and Find Full Text PDF

Introduction: Gestational age, ethnicity, assay method, thyroid autoimmunity and iodine status of the community affect thyroid hormone levels in pregnancy, and there is a need to establish trimester-specific reference ranges for thyroid hormones across different regions of the world. There was no previous study regarding this from this part of the country. The aim of this study was to establish trimester-specific reference range for thyroid hormones during pregnancy in a tertiary care centre in Southern Odisha.

View Article and Find Full Text PDF